207 related articles for article (PubMed ID: 32797261)
1. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
[TBL] [Abstract][Full Text] [Related]
2. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
[TBL] [Abstract][Full Text] [Related]
4. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
5. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
6. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
[TBL] [Abstract][Full Text] [Related]
7. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
[TBL] [Abstract][Full Text] [Related]
8. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Werntz RP; Pearce SM; Eggener SE
Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
[TBL] [Abstract][Full Text] [Related]
9. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
[TBL] [Abstract][Full Text] [Related]
10. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
Cheney SM; Andrews PE; Leibovich BC; Castle EP
BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
[TBL] [Abstract][Full Text] [Related]
11. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
13. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
Garg H; Mansour AM; Psutka SP; Kim SP; Porter J; Gaspard CS; Dursun F; Pruthi DK; Wang H; Kaushik D
BJU Int; 2023 Jul; 132(1):9-30. PubMed ID: 36754376
[TBL] [Abstract][Full Text] [Related]
14. Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours.
Ohlmann CH; Saar M; Pierchalla LC; Zangana M; Bonaventura A; Stöckle M; Siemer S; Heinzelbecker J
Sci Rep; 2021 May; 11(1):10700. PubMed ID: 34021196
[TBL] [Abstract][Full Text] [Related]
15. Robotic-assisted retroperitoneal lymph node dissection for testicular cancer.
Gereta S; Hung M; Hu JC
Curr Opin Urol; 2023 Jul; 33(4):274-280. PubMed ID: 37014761
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA
J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613
[TBL] [Abstract][Full Text] [Related]
17. Robotic versus Laparoscopic Retroperitoneal Lymph node Dissection for Clinical Stage I Non-seminomatous Germ Cell Tumor of Testis: A Comparative Analysis.
Xu Y; Li H; Wang B; Gu L; Gao Y; Fan Y; Yao Y; Fam X; Ma X; Zhang X
Urol J; 2021 Oct; 18(6):618-622. PubMed ID: 34606083
[TBL] [Abstract][Full Text] [Related]
18. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]